4K Versus 3D Total Laparoscopic Bilateral Oophorectomy: Tools in Comparison

Launched by AZIENDA SANITARIA-UNIVERSITARIA INTEGRATA DI UDINE · Dec 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different types of laparoscopic surgery tools—4K and 3D vision systems—to see if the 4K system helps trainee surgeons perform a specific surgery called bilateral oophorectomy, which involves removing both ovaries. This trial focuses on women aged 65 to 74 who need this surgery for non-cancerous (benign) ovarian conditions. The goal is to find out if the clearer image provided by the 4K system can improve the surgery experience and outcomes compared to the 3D system.

To be eligible for this trial, participants should have a benign ovarian condition that requires surgery, have a good overall health score (ASA score of less than 3), and must not be pregnant or have certain pelvic infections. Additionally, they should not have had any major abdominal surgeries in the past. If you qualify and decide to participate, you can expect to be part of a study that could help improve surgical procedures for future patients. It’s important to know that this trial is not yet recruiting, meaning they are still in the process of preparing to start enrolling participants.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with benign ovarian pathology requiring bilateral oophorectomy
• • ASA score \<3
• • Patients who have signed the appropriate informed consent
• • Patients who are not pregnant or diagnosed with pelvic inflammatory disease
• • No history of prior major abdominal surgery
• Exclusion Criteria:
• • Suspected neoplastic pathology
• • Patients not eligible for surgery